RyR1 Structural Alterations Explain Statin-Associated Muscle Dysfunction
December 16, 2025
Brand Name :
natacyn
Synonyms :
natamycin
Class :
Antifungal Agent, Ophthalmic
Dosage forms and strengths Â
suspension (Ophthalmic)Â
Natacyn- 5% (15 mL)Â
For Ophthalmic
Put one drop in each conjunctival sac every couple of hours
Reduce the dose to 1 drop every 3-4 hours each day after 3-4 days
The standard treatment duration typically spans from two-three weeks, or until the active fungal keratitis is fully resolved
To ensure the complete elimination of the organism, it may be beneficial to gradually decrease the dosage at intervals of four-seven days
Not indicatedÂ
Refer adult dosingÂ
Actions and Spectrum:Â
Action:
natamycin exerts its antifungal action by inhibiting the growth and proliferation of various fungi, including yeast and molds. It disrupts the fungal cell membrane, explicitly targeting the ergosterol component. Ergosterol is a crucial component of the fungal cell membrane, like how cholesterol is essential for the structure and function of human cells. natamycin attaches itself to ergosterol, a key component of the fungal cell membrane. This interaction results in the formation of pores or openings in the membrane, which leads to the release of intracellular contents and, consequently, the demise of the fungal organism.Â
Spectrum:Â
Ocular Infections: natamycin is widely used as an ophthalmic antifungal agent to treat fungal keratitis, a severe cornea infection caused by fungi.Â
Skin and Mucosal Infections: natamycin can be employed topically to treat fungal infections affecting the skin, nails, and mucous membranes, such as oral thrush (oral candidiasis) and vaginal yeast infections (vulvovaginal candidiasis).Â
Frequency not defined Â
Respiratory: DyspneaÂ
Ophthalmic: eye pain, corneal opacity, periorbital edema, eye irritation, hyperemia, Eye discomfortÂ
Nervous system: ParesthesiaÂ
Hypersensitivity: Hypersensitivity reactionÂ
Cardiovascular: Chest painÂ
Black Box Warning:Â Â
None
Contraindication/Caution:Â Â
Hypersensitivity: Individuals with a known hypersensitivity or allergic reaction to natamycin or its components should not use this medication.Â
Viral Infections: natamycin is specifically designed to target and treat fungal infections. It is not effective against viral infections, such as those caused by viruses like herpes or adenovirus. Using natamycin to treat viral infections is not appropriate and may not provide any benefit.Â
Use in Systemic Infections: natamycin is meant for topical use, primarily in the eye. It is not intended for treating systemic fungal infections or infections in other parts of the body. The drug’s efficacy and safety have not been established for systemic use.Â
Use in Eye Trauma: natamycin should not be used in cases of eye trauma or injuries, as it is specifically indicated for fungal infections. Other appropriate treatments should be sought for traumatic eye injuries.Â
Concurrent Bacterial Infections: natamycin is not effective against bacterial infections. If a patient has both bacterial and fungal infections in the eye, it is essential to differentiate between the two and provide appropriate treatment for each.Â
Pregnancy and Breastfeeding: The safety of natamycin during pregnancy and breastfeeding has not been thoroughly studied The advisable approach is typically to refrain from using the medication during pregnancy unless the potential benefits outweigh the potential risks. Pregnant and breastfeeding individuals should consult their healthcare providers before using natamycin.Â
Children: While natamycin is commonly used in pediatric patients, its use should be done under the supervision of a healthcare professional, especially in infants and very young children.Â
Pregnancy warnings:    Â
Pregnancy category: N/AÂ
Lactation: Excreted into human milk is unknownÂ
Pregnancy Categories:        Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â Â
natamycin is an antifungal medication used in ophthalmology and food preservation.Â
Pharmacodynamics:Â Â
natamycin works by inhibiting the growth and replication of fungi, specifically yeast and filamentous fungi. The mechanism of action involves disrupting the synthesis of ergosterol, a vital element in the formation of fungal cell membranes. Without adequate ergosterol, the integrity of the fungal cell membrane is compromised, leading to cell death and inhibition of further fungal growth.  Â
Pharmacokinetics:Â
AbsorptionÂ
natamycin is not well absorbed through the gastrointestinal tract when taken orally. Therefore, it is primarily administered topically, such as in the form of eye drops, ointments, or creams. When applied topically, natamycin is absorbed through the affected tissues, such as the conjunctiva in the case of eye drops.Â
DistributionÂ
After absorption through the topical route, natamycin may enter the bloodstream to some extent, but the systemic distribution is limited due to its poor oral bioavailability. It is more likely to remain localized at the site of application, such as the eyes or other mucous membranes.Â
MetabolismÂ
natamycin is minimally metabolized in the body. The liver primarily metabolizes drugs, but natamycin’s limited systemic absorption reduces its exposure to hepatic metabolism. Instead, it likely undergoes some enzymatic breakdown at the site of application or gets excreted unchanged.Â
Excretion and EliminationÂ
Since natamycin is minimally absorbed systemically, most of the drug is excreted unchanged. Most of it is likely eliminated from the body through the feces after passing through the gastrointestinal tract. A small portion may also be excreted via the kidneys, but this is likely a minor route of elimination.Â
Administration: Â
Ophthalmic:Â Â
Skin Infections (Topical use):Â
Patient information leafletÂ
Generic Name: natamycinÂ
Why do we use natamycin? Â
Ophthalmic Use: natamycin is commonly used in the form of eye drops or ophthalmic ointments to treat fungal eye infections, specifically those caused by susceptible fungi like Candida and Aspergillus. It is effective in treating conditions such as fungal keratitis, conjunctivitis, and other ocular infections.Â
Topical Use: natamycin can be used as a topical cream or ointment for superficial skin infections caused by fungi. It is effective against various dermatophytes, yeasts, and molds that can cause skin infections, such as athlete’s foot (tinea pedis), ringworm (tinea corporis), and candidiasis.Â
Â